Clinical Trial Update: Combination of Sulfonylureas and Insulin Glargine Outpatient Therapy for Unstable Diabetes and Impending DKA [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated outpatient therapy combining a sulfonylurea with insulin glargine for unstable Type 2 diabetes at risk of ketoacidosis; the study has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• Sulfonylureas (class)

Snippet

Sponsor: Cook County Health | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED